Organization
Invex Therapeutics
1 clinical trial
Clinical trial
A Phase III Randomised, Placebo-controlled, Double-blind, Multi-centre, Clinical Trial to Determine the Efficacy and Safety of Presendin in Idiopathic Intracranial HypertensionStatus: Terminated, Estimated PCD: 2023-09-18